Medical Laboratory Testing Services Market, 2022 - Cardiac, Molecular Diagnostic and Genomic
DUBLIN, October 3, 2017 /PRNewswire/ --
The "Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department by Country. 2017 to 2022 - Global Version" report has been added to Research and Markets' offering.
Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Global Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2017 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.
Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.
Trends like:
- changing demographics
- emerging economies and global prosperity
- biotechnology advances in genetics
- healthcare expansion in China
- climate change
- globalization
- automation
Key Topics Covered:
1. Introduction and Market Definition
1.1 The Growing Demand for Clinical Testing
1.2 Defining the Opportunity
1.3 Methods and Sources
1.4 U.S. Medical Market and Clinical Laboratory Testing - Perspective
2. Overview of a Dynamic Market
2.1 Market Players - Roles & Impacts
2.2 Segmentation - Different Approaches
2.3 Structure of Clinical Testing Industry
2.4 Profiles of Key Companies
2.5 National and Regional Diversity
3. Trends Driving a Changing Market
3.1 Growth Is Pushed From Many Sides
3.2 Factors At Work To Shrink The Market
3.3 Automation
3.4 Environment and Evolution
3.5 Diagnostic Technology Development
4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments
4.1 Recent Developments - Importance and How to Use This Section
4.2 LabCorp explores acquisition of clinical trials firm PPD
4.3 Digipath Enters into Letter of Intent to Acquire Clinical Lab Companies
4.4 PSP to acquire European medical lab services company
4.5 Mars, Incorporated to Acquire VCA Inc.
4.6 Caprion Biosciences Acquires the Immune Monitoring Laboratory from ImmuneHealth
4.7 Takara Bio USA Holdings and Rubicon Genomics Announce Merger Agreement
4.8 Instrumentation Laboratory Acquires CA Casyso AG
4.9 Schryver Medical Completes Acquisitions of Professional Clinical Laboratory, Inc.
4.10 Grail, Illumina's billion-dollar diagnostics startup
4.11 Grifols acquires Hologic's blood screening unit for $1.85bn
4.12 Bio-Rad Laboratories to buy US firm RainDance Technologies
4.13 Abbott Laboratories to buy St. Jude Medical for $25 billion
4.14 CombiMatrix Gets Serious About Potential M&A Options in Wake of $8M Offering
4.15 Abbott to Acquire Alere, Becoming Leader in Point of Care Testing
4.16 Achieving Dx Ambitions Key to Avant-Amarantus-Theranostics Merger
4.17 LabCorp Agrees to Acquire Assets of Pathology Inc.
4.18 NeoGenomics Completes Acquisition of Clarient, Inc.
4.19 FDA Gets Pushback on Move to Regulate Lab Developed Tests
4.20 Cancer Genetics, Inc. Announces Partnership
4.21 Theranos plans to close all its clinical labs
4.22 Forte Capital Lowers stake in Laboratory Corp.
4.23 US Oncology Network Selects Myriad Genetics
4.24 Pyxant Labs Commences Clinical Laboratory Testing Services
4.25 Viewics Launches Diabetes Management
4.26 Alpha Genomix And Rx30 Partner
4.27 LabCorp Doubles Testing Capacity Of Covance
4.28 LabCorp to acquire clinical laboratories from Mount Sinai
4.29 PerkinElmer to buy Germany's Euroimmun for about $1.3 billion
4.30 LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash
4.31 Precipio Diagnostics and Transgenomic Complete Merger
4.32 $550 Dock Turns a Smartphone into a Medical Lab
4.33 LabCorp & Interpace Extend Deal, Boost Cancer Portfolio
5. Country Market Sizes - North America 2014 to 2022
5.1 United States of America 2014 to 2022
5.2 Canada 2014 to 2022
6. Country Markets - Europe 2014 to 2022
6.1 France 2014 to 2022
6.2 Germany 2014 to 2022
6.3 United Kingdom 2014 to 2022
6.4 Spain 2014 to 2022
6.5 Italy 2014 to 2022
6.6 Russia 2014 to 2022
6.7 Remainder of Europe and Former Soviet Union 2014 to 2022
7. Country Markets - Asia Pacific 2014 to 2022
7.1 China 2014 to 2022
7.2 Japan 2014 to 2022
7.3 South Korea 2014 to 2022
7.4 India 2014 to 2022
7.5 Australia 2014 to 2022
7.6 Rest of Asia Pacific 2014 to 2022
8. Country Markets - Latin America, Africa & The Middle East 2014 to 2022
8.1 Brazil 2014 to 2022
8.2 Mexico 2014 to 2022
8.3 Remainder of Latin America 2014 to 2022
8.4 Africa & The Middle East 2014 to 2022
9. Global Market Summary 2014 to 2022
9.1 Global Market 2014 to 2022
10. The Future of the Clinical Laboratory
Companies Mentioned
- Abbott Laboratories
- Acibadem Labmed Laboratory
- ACM Medical Laboratory
- Adicon Clinical Laboratories
- Alere
- Alpha Genomix
- American Bio-Clinical Laboratories, Int'l
- American Pathology Partners, Inc.
- ARUP Laboratories, Inc.
- Ascend Clinical, LLC
- Aurora Diagnostics, LLC
- Avant-Amarantus-Theranostics
- B.P. CLINICAL LAB
- Bio-Rad Laboratories
- Bio-Reference Laboratories, Inc.
- Bioscientia Institut fuer Medizinische Diagnostik GmbH
- CA Casyso AG
- Cancer Genetics, Inc.
- Caprion Biosciences
- Chiltern
- Clarient, Inc.
- Clinical Lab Companies
- Clinical Reference Laboratory, Inc.
- Clongen Laboratories LLC
- CombiMatrix
- CompuNet Clinical Laboratories, LLC
- Covance
- Diagnsticos da Amrica (DASA)
- Dian Diagnostics
- Digipath
- DL Reference Laboratory
- Enzo Biochem, Inc.
- Eurofins Scientific
- Euroimmun
- Exagen Diagnostics, Inc.
- Forte Capital
- Genomic Health, Inc.
- Genzyme Corporation
- Grail
- Gribbles Pathology
- Grifols
- Hologic
- Illumina
- ImmuneHealth
- Instrumentation Laboratory
- Integrated Regional Laboratories, Inc.
- Kingmed Diagnostics
- LabCorp
- Laboratory Corporation of America
- Lifelabs Medical Laboratory Services
- Mars, Incorporated
- Mid America Clinical Laboratories, LLC
- Miraca Life Sciences, Inc.
- Mount Sinai
- Myriad Genetics, Inc.
- NeoGenomics
- Pathology Inc.
- PerkinElmer
- Precipio Diagnostics
- Professional Clinical Laboratory, Inc.
- PSP
- Psychemedics Corp.
- Pyxant Labs
- Quest Diagnostics
- RainDance Technologies
- Rubicon Genomics
- Rx30
- Schryver Medical
- Sonic Healthcare Limited
- Spectra Laboratories, Inc.
- St. Jude Medical
- Takara Bio USA Holdings
- The Doctor's Laboratory (Sonic Healthcare U.K.)
- Theranos
- Transgenomic
- Unilabs SA
- VCA Inc.
- Viewics
- Viracor Laboratories
For more information about this report visit https://www.researchandmarkets.com/research/z2dnqf/medical
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article